Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Portal vein stenting in recurrent or locally advanced peri-hilar cholangiocarcinoma.
De Bellis M, Contro A, Bianco A, Gasparini C, Tripepi M, La Raja M, Alaimo L, Conci S, Campagnaro T, Guglielmi A, Mansueto G, Ruzzenente A. De Bellis M, et al. Among authors: alaimo l. Eur J Surg Oncol. 2024 Mar;50(3):107984. doi: 10.1016/j.ejso.2024.107984. Epub 2024 Jan 30. Eur J Surg Oncol. 2024. PMID: 38335874
Minimally Invasive Versus Open Liver Resection for Hepatocellular Carcinoma in the Setting of Portal Vein Hypertension: Results of an International Multi-institutional Analysis.
Ruzzenente A, Bagante F, Ratti F, Alaimo L, Marques HP, Silva S, Soubrane O, Endo I, Sahara K, Beal EW, Lam V, Poultsides GA, Makris EA, Popescu I, Alexandrescu S, Martel G, Workneh A, Hugh TJ, Guglielmi A, Aldrighetti L, Pawlik TM. Ruzzenente A, et al. Among authors: alaimo l. Ann Surg Oncol. 2020 Sep;27(9):3360-3371. doi: 10.1245/s10434-020-08444-3. Epub 2020 Apr 9. Ann Surg Oncol. 2020. PMID: 32274662
Application of Hazard Function to Investigate Recurrence of Intrahepatic Cholangiocarcinoma After Curative-Intent Liver Resection: A Novel Approach to Characterize Recurrence.
Alaimo L, Moazzam Z, Brown ZJ, Endo Y, Ruzzenente A, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Shen F, Soubrane O, Koerkamp BG, Endo I, Pawlik TM. Alaimo L, et al. Ann Surg Oncol. 2023 Mar;30(3):1340-1349. doi: 10.1245/s10434-022-12463-7. Epub 2022 Aug 27. Ann Surg Oncol. 2023. PMID: 36029379
Impact of tumor burden score on timing and patterns of recurrence after curative-intent resection of hepatocellular carcinoma.
Moazzam Z, Lima HA, Alaimo L, Endo Y, Shaikh CF, Ratti F, Marques HP, Soubrane O, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM. Moazzam Z, et al. Among authors: alaimo l. Surgery. 2022 Nov;172(5):1448-1455. doi: 10.1016/j.surg.2022.07.019. Epub 2022 Aug 26. Surgery. 2022. PMID: 36031442
[No title available]
[No authors listed] [No authors listed] PMID: 36097298
A comprehensive preoperative predictive score for post-hepatectomy liver failure after hepatocellular carcinoma resection based on patient comorbidities, tumor burden, and liver function: the CTF score.
Alaimo L, Endo Y, Lima HA, Moazzam Z, Shaikh CF, Ruzzenente A, Guglielmi A, Ratti F, Aldrighetti L, Marques HP, Cauchy F, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Hugh T, Endo I, Pawlik TM. Alaimo L, et al. J Gastrointest Surg. 2022 Dec;26(12):2486-2495. doi: 10.1007/s11605-022-05451-5. Epub 2022 Sep 13. J Gastrointest Surg. 2022. PMID: 36100827
116 results